US6541605B1ExpiredUtility

Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases

49
Assignee: UNIV MASSACHUSETTSPriority: May 19, 1995Filed: Apr 7, 1998Granted: Apr 1, 2003
Est. expiryMay 19, 2015(expired)· nominal 20-yr term from priority
A61P 37/06A61P 9/10A61P 9/02A61P 35/00A61P 37/00A61P 9/00A61P 29/00Y10S435/81C07K 14/4705C07K 14/82C12N 9/12C12Q 1/485A61P 19/02A61K 38/00Y10T436/143333A61P 11/00C12Q 1/6883A61P 13/12C12N 2710/10322C12N 9/1205C12Q 2600/158G01N 2500/02A61P 17/02A61P 1/16C07K 14/4736A61P 17/06Y10S435/975C07K 14/005
49
PatentIndex Score
5
Cited by
22
References
10
Claims

Abstract

Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
       1. A substantially pure human mitogen-activated protein kinase kinase (MKK) polypeptide having serine, theonine, and tyrosine kinase activity, and phosphorylating human mitogen-activated protein (MAP) kinase p38comprising the amino acid sequence of SEQ ID NO:2. 
     
     
       2. A substantially pure human mitogen-activated protein kinase kinase (MKK) polypeptide having serine, theonine, and tyrosine kinase activity, and phosphorylating human mitogen-activated protein (MAP) kinase p38 comprising the amino acid sequence of SEQ ID NO:4. 
     
     
       3. A substantially pure human mitogen-activated protein kinase kinase (MKK) polypeptide having serine, threonine, and tyrosine kinase activity, and phosphorylating human mitogen-activated protein (MAP) kinase p38, further characterized in that the polypeptide phosphorylates human mitogen-activated protein (MAP) kinase JNK comprising the amino acid sequence of SEQ ID NO:6. 
     
     
       4. A substantially pure human mitogen-activated protein kinase kinase (MKK) polypeptide having serine, threonine, and tyrosine kinase activity, and phosphorylating human mitogen-activated protein (MAP) kinase p38, further characterized in that the polypeptide phosphorylates human mitogen-activated protein (MAP) kinase JNK comprising the amino acid sequence of SEQ ID NO:8. 
     
     
       5. A substantially pure human mitogen-activated protein kinase kinase (MKK) polypeptide having serine, threonine, and tyrosine kinase activity, and phosphorylating human mitogen-activated protein (MAP) kinase p38, further characterized in that the polypeptide phosphorylates human mitogen-activated protein (MAP) kinase JNK comprising the amino acid sequence of SEQ ID NO:10. 
     
     
       6. A purified antibody which binds specifically to a polypeptide of  claim 1 . 
     
     
       7. A purified antibody which binds specifically to a polypeptide of  claim 2 . 
     
     
       8. A purified antibody which binds specifically to a polypeptide of  claim 3 . 
     
     
       9. A purified antibody which binds specifically to a polypeptide of  claim 4 . 
     
     
       10. A purified antibody which binds specifically to a polypeptide of  claim 5 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.